Alcon Pharmaceuticals Moscow (Alkon Pharmatsevtika)

The headquarters in Fort Worth, the State of Texas, the USA. More than 22,000 employees (May, 2012). 75 regional representative offices. Presence in the markets more than 180 countries.

Alkon offers a broad spectrum of ophthalmologic products for the solution of such problems as a cataract, glaucoma, diseases of a retina, violation of a refraction, a syndrome of "a dry eye", allergic, infectious and inflammatory diseases of eyes.

Merge with Novartis allowed to integrate the Alkon, SIBA VIZhN and Novartis Oftalmiks resources therefore became Alkon the second in value business division of Novartis group and also got access to resources of Institute of the Biomedical researches "Novartis" and developments of SIBA VIZhN in production of contact lenses.

For May, 2012 more than 2000 specialists are engaged in research activity in which the company is going to invest about $4 billion within the next 5 years.

Business in Russia

The Russian representative office of Alkon was founded in 1994 in St. Petersburg, and since 2000 control of activity of the company in Russia is exercised of the Moscow office Alkon Pharmatsevtika LLC.

Partners of the company are such organizations as scientific research institute of Eye Diseases of Helmholtz, MNTK "Eye Microsurgery" of the academician S.N. Fyodorov, scientific research institute of Eye Diseases of the Russian Academy of Medical Science, scientific centers, multi-profile hospitals and clinics.

Alkon supports educational programs for ophthalmologists and oftalmokhirurg based on three educational laboratories which are fully completed by the necessary equipment and supplies.